Odyssey Therapeutics, Inc.
ODTX
$20.73
$0.010.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 310.58M | 175.75M | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 10.89M | 9.35M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 321.46M | 185.10M | -- | ||
|
|
|||||
| Total Current Assets | 321.46M | 185.10M | -- | ||
| Net Property, Plant & Equipment | 21.92M | 24.48M | -- | ||
| Long-term Investments | 14.10M | 14.07M | -- | ||
| Goodwill | 14.10M | 14.07M | -- | ||
| Total Other Intangibles | 86.00K | 160.00K | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 3.79M | 5.26M | -- | ||
| Total Assets | 483.85M | 229.07M | -- | ||
|
|
|||||
| Total Accounts Payable | 7.67M | 8.22M | -- | ||
| Total Accrued Expenses | 11.50M | 6.77M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 5.47M | 5.37M | -- | ||
| Total Finance Division Other Current Liabilities | 3.66M | 1.85M | -- | ||
| Total Other Current Liabilities | 3.66M | 1.85M | -- | ||
| Total Current Liabilities | 28.30M | 22.21M | -- | ||
|
|
|||||
| Total Current Liabilities | 28.30M | 22.21M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 19.36M | 20.75M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 14.97M | 6.24M | -- | ||
| Total Liabilities | 62.63M | 49.21M | -- | ||
|
|
|||||
| Common Stock & APIC | 1.08B | 82.85M | -- | ||
| Retained Earnings | -659.19M | -606.40M | -- | ||
| Treasury Stock & Other | -505.00K | -147.00K | -- | ||
| Total Common Equity | 421.22M | -523.69M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 703.56M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 703.56M | -- | ||
|
|
|||||
| Total Common Equity | 421.22M | -523.69M | -- | ||
| Total Preferred Equity | -- | 703.56M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 421.22M | 179.86M | -- | ||
|
|
|||||